Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

The final amendments to the Québec Charter of the French Language (“Charter”) introduced by Bill 96 will come into force on ...